News on in vitro diagnostics for allergy testing.

The Phadia 200 quantifies clinically relevant antibodies in blood and can perform up to 700 different ImmunoCAP and EliA tests.

Microdrop will license the rights to market SQI's celiac and wheat allergy, and arthritis tests direct to consumers.

In a study, Medical Research Council scientists demonstrated that a test that uses flow cytometry and looks for the CD63 protein in mast cells had 98 percent specificity.

ALK will market Rellergen's Bio-IC lab-on-a-chip technology to more than 190 hospitals in China. The technology uses a blood sample to screen up to 20 different allergens.